Skip to content
★ Sign in to follow
EG

Emanuel Gunnarsson Eriksson

EQL Pharma AB
Total declarations
4
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (2 ops.)
€64k

Latest filing published 26 Sept 2022 for EQL Pharma AB, €34k.

Filing timeline

BuySale
Emanuel Gunnarsson Eriksson

Insider track record

Disclosed buys
0
Disclosed sells
2
Signal history

Emanuel Gunnarsson Eriksson: trading record in brief

This profile gathers the share dealings of Emanuel Gunnarsson Eriksson in EQL Pharma AB. Between 16 September 2021 and 22 September 2022, the trades on record add up to 4 filings.

The open-market record consists of 2 sales worth €64k, with no purchase. So far in 2022, the count stands at no purchases and 1 sale.

The newest entry dates from 26 September 2022: an open-market sale of €34k, in EQL Pharma AB. Typically, a trade is published a median of 4 days after it takes place. For comparison, MAR article 19 gives managers three business days to notify a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.

Companies and markets linked to Emanuel Gunnarsson Eriksson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total
  • ▼
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesEQL Pharma AB
    369,980 SEK8FI-SE
    13,000 shares@ SEK 28.469.5% of flowAktieISIN SE0005497732FI:csv-13e3ad73ba6949fea32b
  • ▼
    Ekonomichef/finanschef/finansdirektörExecutivesEQL Pharma AB
    300,160 SEK20FI-SE
    8,000 shares@ SEK 37.528.2% of flowAktieISIN SE0005497732FI:csv-763bdc57887cf8975e2d
  • ●
    Ekonomichef/finanschef/finansdirektörExecutivesEQL Pharma AB
    3M SEK0FI-SE
    200,000 shares@ SEK 15.0082.3% of flowOptionISIN SE0005497732FI:csv-89070e4e9ca9449a27d6

3 of 3 declarations